Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial

Title:	Pembrolizumab and chemotherapy in high-risk, early-stage, ER+/HER2− breast cancer: a randomized phase 3 trial
Authors:	Cardoso, Fatima^{Aff1, IDs41591024034157_cor1}; O’Shaughnessy, Joyce^Aff2; Liu, Zhenzhen^Aff3; McArthur, Heather^Aff4; Schmid, Peter^Aff5; Cortes, Javier^{Aff6, Aff7, Aff8, Aff9, Aff10}; Harbeck, Nadia^Aff11; Telli, Melinda L.^Aff12; Cescon, David W.^Aff13; Fasching, Peter A.^Aff14; Shao, Zhimin^Aff15; Loirat, Delphine^Aff16; Park, Yeon Hee^Aff17; Fernandez, Manuel Gonzalez^Aff18; Rubovszky, Gábor^Aff19; Spring, Laura^Aff20; Im, Seock-Ah^Aff21; Hui, Rina^{Aff22, Aff23}; Takano, Toshimi^Aff24; André, Fabrice^Aff25; Yasojima, Hiroyuki^Aff26; Ding, Yu^Aff27; Jia, Liyi^Aff27; Karantza, Vassiliki^Aff27; Tryfonidis, Konstantinos^Aff27; Bardia, Aditya^Aff28
Source:	Nature Medicine. 31(2):442-448
Database:	Springer Nature Journals